
Metformin may not offer the same cardioprotective benefits to those without type 2 diabetes mellitus that it does to those with the condition.
Metformin may not offer the same cardioprotective benefits to those without type 2 diabetes mellitus that it does to those with the condition.
Counting carbohydrates is a widely recommended strategy for controlling blood sugar in type 1 diabetes mellitus patients, but a recent review reports that the approach may not improve glycemic control much more than usual care.
Young women who frequently binge eat are at an increased risk for developing diabetes, regardless of their body mass index.
New research suggests that patients who are diagnosed with T2DM when they are younger than 65 years have worse glycemic control than those who are diagnosed at older ages.
Understanding stroke is the first step in knowing how to prevent it.
Understanding stroke is the first step in knowing how to prevent it.
The FDA has approved Nesina (alogliptin) tablets, along with diet and exercise, for improving control of blood sugar levels in patients with type 2 diabetes mellitus.
Jonathan G. Marquess, PharmD, CDE, explains why going out of your way to serve diabetes patients can help grow your pharmacy's business.
Jonathan G. Marquess, PharmD, CDE, discusses the role that pharmacists can play in helping patients improve management of their diabetes.
A discussion of current and emerging pharmacotherapy options for cystic fibrosis patients.
A case involving a 43-year-old female with a history of type 2 diabetes who is admitted for hyperglycemia as well as complaints of dysuria and increased urinary frequency.
New guidelines from the American Heart Association and American College of Cardiology eliminate strict LDL cholesterol targets and include stroke risk in determining whether patients should take statins.
Our monthly round-up of new prescription products.
Jonathan G. Marquess, PharmD, CDE, explains why he decided to focus on caring for diabetes patients at his pharmacy.
Interim results from Project IMPACT: Diabetes, an APhA Foundation program, suggest that pharmacists working as part of a multidisciplinary team helped improve a range of outcomes for diabetes patients.
The impact of the community pharmacist on insulin therapy is explored.
Approximately 80% to 90% of patients diagnosed with type 2 diabetes mellitus are also obese.
Pharmacists can help improve adherence by providing patient counseling and guidance about the importance of needle selection and appropriate injection technique.
Research from the University of Pittsburgh suggests the possibility of a diabetes breathalyzer that could be used in place of blood testing.
Infants already at an increased genetic risk for developing type 1 diabetes mellitus may be even more likely to be diagnosed with the condition if they are introduced to solid foods too early or too late.
The results of a recent study show that hypoglycemia is common among type 2 diabetes patients across all levels of glycemic control.
Increasing red meat consumption was associated with a subsequent increase in risk for developing type 2 diabetes mellitus in a recent subanalysis of 3 cohort studies.
A guide to mastering new skills for diabetes patient care in just 10 steps.
Patients with diabetes can take measures to prevent or control neuropathy.